Thursday, April 23, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Perspectives

Psychologists Should Talk Publicly about Their Own Mental Illnesses

The Conversation by The Conversation
April 3, 2024
in Perspectives
0
Psychologists Should Talk Publicly about Their Own Mental Illnesses

Psychologists are starting to talk publicly about their own mental illnesses – and patients can benefit

mental illnesses
Mental health professionals who have experienced mental illness have much to offer to their patients.
Bulat Silvia/iStock/Getty Images Plus via Getty Images

Andrew Devendorf, University of South Florida and Sarah Victor, Texas Tech University

From sports and entertainment celebrities like Simone Biles, Ariana Grande and Ryan Reynolds to everyday social media users on Facebook, Twitter and TikTok, more people are talking publicly about mental health.

Yet both students and professionals across fields have long been advised that talking openly about their own mental health experiences risks negative judgments from co-workers and supervisors, which can potentially damage their careers. Ironically, even professionals in mental health fields are advised to conceal their own experiences with mental illness.

This culture of silence is counter to what psychologists know to be true about battling stigma: that talking openly about mental health can help reduce stigma and encourage others to seek help.

Stigmatizing openness about mental illness can also result in the systemic discrimination against and exclusion from mental health professions of people who can make valuable contributions to the field – whether in spite of or because of their unique mental health experiences.

We are a doctoral candidate and an assistant professor of clinical psychology who have both experienced mental illness. In a recent study, we explored how common mental health issues are among clinical psychologists and trainees, and whether those issues affected them professionally.

In a related commentary, we and our psychology colleagues wrote openly about our own experiences with mental illness to show others that success in mental health careers is possible for people who currently live, or have lived, with mental illness.

Psychologists are people, too

In a forthcoming peer-reviewed study, almost 1,700 psychology faculty members and trainees completed an online survey that asked about their mental health experiences. This is the largest study to date on the rates of mental illness in graduate programs that train clinical, counseling and school psychologists.

Our survey asked participants two separate questions: whether they had ever experienced “mental health difficulties” and if they had ever been diagnosed with a mental illness by a professional. Asking both questions was important, because some mental health difficulties are not labeled as specific conditions, and not all respondents may have had access to a mental health provider who could make a formal diagnosis.

Over 80% of all respondents reported having mental health difficulties at some point, and 48% reported having a diagnosed mental illness. These rates are similar to rates of mental illness in the general population.

Our findings show that, far from being immune to the conditions they treat in others, psychologists grapple with mental health difficulties or illnesses just as much as their patients do.

Stephen Lewis, an associate professor of clinical child and adolescent psychology at the University of Guelph in Ontario, tells the story of his own life. These experiences led him to specialize in the study of self-harm – called “nonsuicidal self-injury” – in the profession.

Mental illnesses are leading causes of disability worldwide. This fact may partly explain why there’s a stigma among psychology professionals about disclosing them: Some may see mental illness as an insurmountable handicap to being effective at researching mental illness or treating it in others.

However, in our survey of psychology faculty members and trainees, 95% of respondents with mental health difficulties reported having “no” or “mild” professional problems related to these experiences. Over 80% of those with diagnosed mental illness reported the same.

This finding highlights that experiencing mental illness is not by any means a barrier to being a capable and effective psychologist.

Stigma as a barrier to inclusion

Through another upcoming study, we identified some of the structural barriers within clinical psychology that may discourage psychologists from talking about their own mental illness.

One key barrier is that – again, ironically – stigma toward mental illness exists from within the mental health profession. We have found that psychologists and trainees with mental illness may be unfairly viewed as damaged, incompetent or hard to work with by their colleagues. We based this conclusion on our personal experiences in the profession, combined with the large body of research on the dynamics of disclosing mental illness.

Previous research has found that sharing one’s mental health difficulties, disability or illness in a training setting may result in lost professional opportunities, such as being hired or promoted or winning an award.

However, research also shows that sharing one’s mental illness may open up other opportunities to receive support and accommodations on the job, such as adjustment of job tasks, work schedules and time and performance expectations.

Lived experience counts

As therapists ourselves who have worked with hundreds of clients, we have found that our mental health struggles help us understand and empathize with the challenges faced by our patients.

Research suggests that we are not alone. Studies show that therapists may use their experiences to inform how they work with clients. In fact, some widely used and scientifically backed therapies were developed by psychologists with lived mental health experience – such as “dialectical behavior therapy,” which aims to help clients live in the moment, deal with stress and emotions in healthy ways and improve relationships.

Marsha Linehan talks about how she used her own mental health experiences to develop dialectical behavioral therapy.

As research scientists, we have found that our mental health experiences not only inform our ideas but also help us grapple effectively with the inevitable setbacks that come with a profession defined by endless hours of data collection, grant writing and a publish-or-perish culture.

Having personal experience with mental health challenges reminds us why our work has meaning and is worth the struggle: to help and improve the lives of real people dealing with real traumas and real emotional struggles.

Psychologists ‘coming out’ proud

Although we have chosen to make our struggles public, we are not saying that others like us should feel that they must talk openly about it – or that all psychologists must have had mental health experiences in order to treat patients or do research effectively.

Rather, we believe that psychologists who have chosen to talk about their mental illness may be able to use their positions to destigmatize openness about these health issues – for other mental health providers as well as the patients they serve.

[Interested in science headlines but not politics? Or just politics or religion? The Conversation has newsletters to suit your interests.]

Andrew Devendorf, Doctoral Candidate, Clinical Psychology, University of South Florida and Sarah Victor, Assistant Professor of Clinical Psychology, Texas Tech University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

ShareTweet
The Conversation

The Conversation

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • National Opioid Settlement Injunction

    National Opioid Settlement Injunction

    1 shares
    Share 0 Tweet 0
  • Strategies for Transitioning Off GLP-1 Injections

    1 shares
    Share 0 Tweet 0
  • Biosimilar Economics Through a Benchmark Lens: What WAC and NADAC Reveal About Competition

    0 shares
    Share 0 Tweet 0
  • PBMs as Price Signal Absorbers: How Formulary Architecture Distorts Benchmark Data

    0 shares
    Share 0 Tweet 0
  • The IRA’s Negotiation Mechanism and What Benchmark Data Will Reveal About Its Actual Effect

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy